|
| |
Pangaea Pharmaceuticals Incorporated Pages on BioPortfolio:
Results from other life science and pharmaceutical sites:
BioPortfolio - Pangaea Pharmaceuticals Incorporated
Pangaea Pharmaceuticals Incorporated - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/8050-Pangaea_Pharma...
|
Patent News Peter Steele
Pangaea Pharmaceuticals Inc claims immunogenic peptides. from the HPV E7 protein . Pangaea is developing Biotope-. CD, a DNA-based therapeutic in phase I, ...
http://www.biomedcentral.com/content/pdf/cd-471779.pdf...
|
Microspheres containing plasmid-encoded antigens elicit cytotoxic ...
1Pangaea Pharmaceuticals Inc., 763E Concord Avenue, Cambridge, Massachusetts 02138, USA. 2Department of Chemical Engineering, Massachusetts Institute of ...
http://www.nature.com/nm/journal/v4/n3/abs/nm0398-365.html...
|
Tech Companies M thru Z
Pangaea Pharmaceuticals Inc. developed BIOTOPE therapeutics to treat cervical dysplasia, multiple sclerosis, hepatitis B, and other diseases. PanVera ...
http://www.temple.edu/gsa/links/tech_companies__m__thru_z.ht...
|
UTMB Magazine | Class Notes
ZYCOS was formed from Pangaea Pharmaceuticals, Inc. At Pangaea, Urban oversaw the company’s infectious disease and oncology drug development programs. ...
http://www.utmb.edu/utmbmagazine/archive/05_Fall/class_notes...
|
Microspheres containing plasmid-encoded antigens e...[Nat Med ...
Pangaea Pharmaceuticals Inc., Cambridge, Massachusetts 02138, USA. mlhedley@ pangaea-pharm.com. PMID: 9500615 [PubMed - indexed for MEDLINE] ...
http://www.ncbi.nlm.nih.gov/pubmed/9500615...
|
Nano Chemical Systems Holdings, Inc. Closes Long Term Financial ...
Pangea Ultima Corporation is a privately held company that comprises multiple ... 20 million Nanobac Pharmaceuticals, Inc. (OTC Bulletin Board: NNBP) common
...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...
|
The discovery and use of HLA-associated epitopes a...[Crit Rev ...
Pangaea Pharmaceuticals, Inc., Cambridge, MA 02138, USA. MHC receptors "display" peptide fragments to T cells. These peptides are predominantly derived from ...
http://www.ncbi.nlm.nih.gov/pubmed/9419426...
|
RECOMBINANT DNA ADVISORY COMMITTEE Minutes of Meeting September 12 ...
Dr. Joseph Rokovich (Pangaea Pharmaceuticals, Inc.) noted that without approval authority, the RAC still. has a great deal of impact on human gene transfer ...
http://www4.od.nih.gov/oba/rac/minutes/09-12-97.pdf...
|
Technology Evaluation: HspE7, StressGen Biotechnologies Corp ...
Pangaea (now ZYCOS Inc), Cantab Pharmaceuticals plc and. GlaxoSmithKline plc. Promising rival products include. Pangaea's Biotope and Cantab's TA-CIN to ...
http://www.biomedcentral.com/content/pdf/cd-418373.pdf...
|
|
